TARO-TICAGRELOR DIN 02492571
Health Canada record
| Active ingredient(s) | TICAGRELOR 60 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AC24 TICAGRELOR |
| Original market date | 31-May-2022 |
| Current status date | 31-May-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TICAGRELOR
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02537192 | AG-TICAGRELOR | ANGITA PHARMA INC. | Tablet | TICAGRELOR 90 MG | Marketed |
| 02537184 | AG-TICAGRELOR | ANGITA PHARMA INC. | Tablet | TICAGRELOR 60 MG | Marketed |
| 02482622 | APO-TICAGRELOR | APOTEX INC | Tablet | TICAGRELOR 60 MG | Marketed |
| 02482630 | APO-TICAGRELOR | APOTEX INC | Tablet | TICAGRELOR 90 MG | Marketed |
| 02368544 | BRILINTA | ASTRAZENECA CANADA INC | Tablet | TICAGRELOR 90 MG | Marketed |
| 02455005 | BRILINTA | ASTRAZENECA CANADA INC | Tablet | TICAGRELOR 60 MG | Marketed |
| 02531798 | JAMP TICAGRELOR | JAMP PHARMA CORPORATION | Tablet | TICAGRELOR 60 MG | Marketed |
| 02531801 | JAMP TICAGRELOR | JAMP PHARMA CORPORATION | Tablet | TICAGRELOR 90 MG | Marketed |
| 02529769 | M-TICAGRELOR | MANTRA PHARMA INC | Tablet | TICAGRELOR 90 MG | Marketed |
| 02529750 | M-TICAGRELOR | MANTRA PHARMA INC | Tablet | TICAGRELOR 60 MG | Marketed |
| 02492598 | TARO-TICAGRELOR | TARO PHARMACEUTICALS INC | Tablet | TICAGRELOR 90 MG | Marketed |
| 02471914 | TEVA-TICAGRELOR | TEVA CANADA LIMITED | Tablet | TICAGRELOR 60 MG | Approved |
| 02471922 | TEVA-TICAGRELOR | TEVA CANADA LIMITED | Tablet | TICAGRELOR 90 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25311 | 2021-03-01 | Abbreviated New Drug Submission (ANDS) |
International API supply for TICAGRELOR
23 valid EDQM Certificates of Suitability from 23 holders. 47 active FDA Drug Master Files.
Request a quote for TARO-TICAGRELOR